View Chemistry directory
Nathan Goldfarb

Faculty Member

Dr. Nathan Goldfarb

Biography

Nathan Goldfarb is an Assistant Professor of Chemistry at Utah Valley University in Orem, Utah. He received his bachelor’s degree in biology from the Virginia Polytechnic Institute and State University and Master’s degree in Molecular Biology/Biotechnology from East Carolina University. Following that, he earned his Ph.D. in Biochemistry from the University of Florida. He then accepted a postdoctoral position at the global pharmaceutical, Schering-Plough, where he studied Alzheimer’s disease. He was then hired at Schering-Plough as a Senior Scientist working on the evolution of novel enzymes used in drug synthesis. Realizing his true passion was academics, he returned to the University of Florida for a second postdoctoral position where he has published in the areas HIV, malaria, and tuberculosis drug discovery. His first teaching appointment was at the California Health Sciences University in Clovis, CA. After two years of teaching biochemistry, moved to his current academic position at Utah Valley University.

Education

PhD, University of Florida, 2003

Major: Biochemistry

MS, East Carolina University, 1998

Major: Molecular Biology/Biotechnology

BS, Virginia Polytechnic Institute and State University, 1994

Major: BIology

Teaching

BIOL 3600

Biological Chemistry, Fall 2024

CHEM 3600

Biological Chemistry, Fall 2024

BIOL 3605

Biological Chemistry Lab, Fall 2024

CHEM 3605

Biological Chemistry Lab, Fall 2024

CHEM 1110

Elementary Chemistry for the Health Sciences PP, Fall 2024

CHEM 489R

Undergraduate Research in Chemistry, Fall 2024

BIOL 3600

Biological Chemistry, Summer 2024

CHEM 3600

Biological Chemistry, Summer 2024

CHEM 489R

Undergraduate Research in Chemistry, Summer 2024

BIOL 3600

Biological Chemistry, Spring 2024

CHEM 3600

Biological Chemistry, Spring 2024

BIOL 3605

Biological Chemistry Lab, Spring 2024

CHEM 3605

Biological Chemistry Lab, Spring 2024

CHEM 482R

Chemistry Internship, Spring 2024

CHEM 1110

Elementary Chemistry for the Health Sciences PP, Spring 2024

CHEM 489R

Undergraduate Research in Chemistry, Spring 2024

Presentations

Schumann, Nicholase Charles (Presenter & Author), Goldfarb, Nathan , Johns Hopkins University Division of Infectious Disease, "NS-049-2, A Novel Lead for the Development of Tuberculosis Antibiotics", Johns Hopkins University, Baltimore, MD. (October 12, 2022)
Schumann, Nicholas Charles (Presenter & Author), Goldfarb, Nathan , UVU Chemistry Dept Seminar, "Drug Discovery for TB", Chemistry Dept, UVU. (October 7, 2022)
Goldfarb, Nathan , Presentation to Eric Gardanier and Dan Fairbanks , "United States Patent Application_ Composition and Method for Hip1 Targeting Inhibitor", Chemistry Dept, UVU. (April 28, 2022)
Goldfarb, Nathan , Utah State University Department of Chemistry and Biochemistry Seminar Series, "2.1 Å Crystal Structure of the Mycobacterium tuberculosis Serine Hydrolase, Hip1, in its Anhydro-Form (Anhydrohip1)", Utah State University Department of Chemistry and Biochemistry , Logan, UT. ()
Goldfarb, Nathan , UVU Chemistry Capstone Class, "Drug Discovery for Infectious Diseases", UVU, Orem, UT. ()
Goldfarb, Nathan , UVU Chemistry Capstone Class, "Drug Discovery for Infectious Diseases", UVU, Orem, UT. ()

Scholarly/Creative Works

Goldfarb, Nathan , "Crystal structure of Hip1, a TB drug target, bound with a novel, potent peptidomimetic inhibitor." .
Goldfarb, Nathan , "COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUND" . USPTO.
Goldfarb, Nathan , "COMPOSITION AND METHOD FOR HIP1-TARGETING INHIBITOR COMPOUND (Patent Pending)" . USPTO.
Goldfarb, Nathan , Williams, Brady , Schumann, Nicholas , Perez, Borja , Abell, Andrew , Parish, Tanya , Brooks, Cory , Ostrov, David , "Expression, Purification, and Cocrystallization of Hip1 with NS-049-2, a Lead Compound for the Treatment of Tuberculosis. (2019)." .
Goldfarb, Nathan , Brooks, Cory , Ostrov, David , Kakkad, Suchi , Pena, Karal , Williams, Brady Paul, "2.1Å crystal structure of the Mycobacterium tuberculosis Serine Hydrolase, Hip1, in its anhydro-form. " (vol. 630). Biochemical and Biophysical Research Communications.
Goldfarb, Nathan , Pena, Karla , "Expression, Purification, and Cocrystallization of Hip1 with NS-049-2, a Lead Compound for the Treatment of Tuberculosis. (2021). Utah Conference on Undergraduate Research. Dixie State University." .

Awards

College of Science Champions of Inclusion Award for EID Service

UVU - April, 2023

Faculty Senate Excellence Award

Utah Valley University - March, 2023

Exceptional Efforts During Pandemic Award

Provost Wayne Vaught - May 7, 2020